| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/19/2023 | 20.75% | Oppenheimer | $8 → $22 | Maintains | Outperform |
| 01/18/2023 | 15.26% | Needham | $8 → $21 | Maintains | Buy |
| 12/20/2022 | -17.67% | JP Morgan | $8 → $15 | Upgrades | Underweight → Overweight |
| 11/02/2022 | -56.09% | Needham | $15 → $8 | Maintains | Buy |
| 08/02/2022 | -17.67% | Needham | $16 → $15 | Maintains | Buy |
| 05/03/2022 | 20.75% | Canaccord Genuity | $25 → $22 | Maintains | Buy |
| 05/03/2022 | -17.67% | Oppenheimer | $20 → $15 | Maintains | Outperform |
| 05/03/2022 | — | William Blair | Downgrades | Outperform → Market Perform | |
| 05/03/2022 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 05/03/2022 | -12.18% | Needham | $19 → $16 | Maintains | Buy |
| 04/18/2022 | 9.77% | B. Riley Securities | → $20 | Initiates Coverage On | → Buy |
| 02/17/2022 | 4.28% | Needham | $17 → $19 | Maintains | Buy |
| 02/17/2022 | 4.28% | Raymond James | $26 → $19 | Maintains | Outperform |
| 12/15/2021 | -28.65% | JP Morgan | $17 → $13 | Downgrades | Neutral → Underweight |
| 11/02/2021 | 9.77% | Oppenheimer | $45 → $20 | Maintains | Outperform |
| 11/02/2021 | 42.7% | Raymond James | $41 → $26 | Maintains | Outperform |
| 11/02/2021 | -6.7% | Needham | $19 → $17 | Maintains | Buy |
| 11/02/2021 | -6.7% | JP Morgan | $41 → $17 | Downgrades | Overweight → Neutral |
| 10/19/2021 | 4.28% | Needham | $45 → $19 | Maintains | Buy |
| 08/03/2021 | 125.03% | Raymond James | $50 → $41 | Maintains | Outperform |
| 08/03/2021 | 146.98% | JMP Securities | $64 → $45 | Maintains | Market Outperform |
| 08/03/2021 | 146.98% | Needham | $65 → $45 | Maintains | Buy |
| 05/04/2021 | 174.42% | Raymond James | $58 → $50 | Maintains | Outperform |
| 02/23/2021 | 218.33% | Raymond James | $51 → $58 | Maintains | Outperform |
| 11/03/2020 | 179.91% | Raymond James | $63 → $51 | Maintains | Outperform |
| 11/03/2020 | 201.87% | Oppenheimer | $65 → $55 | Maintains | Outperform |
| 08/05/2020 | 256.75% | Needham | $55 → $65 | Maintains | Buy |
| 08/05/2020 | 245.77% | Raymond James | $49 → $63 | Maintains | Outperform |
| 07/14/2020 | 163.45% | B of A Securities | → $48 | Downgrades | Neutral → Underperform |
| 06/02/2020 | 256.75% | Oppenheimer | $50 → $65 | Maintains | Outperform |
| 05/27/2020 | 229.31% | Canaccord Genuity | $50 → $60 | Maintains | Buy |
| 05/05/2020 | 190.89% | JMP Securities | $50 → $53 | Maintains | Market Outperform |
| 05/05/2020 | 201.87% | Needham | $45 → $55 | Maintains | Buy |
| 03/26/2020 | 146.98% | Needham | $50 → $45 | Maintains | Buy |
| 03/18/2020 | 114.05% | JP Morgan | $51 → $39 | Maintains | Overweight |
| 02/25/2020 | 168.94% | Raymond James | $30 → $49 | Maintains | Outperform |
| 02/25/2020 | 174.42% | Needham | $35 → $50 | Maintains | Buy |
| 02/25/2020 | 179.91% | JP Morgan | $35 → $51 | Maintains | Overweight |
| 11/05/2019 | 86.61% | Canaccord Genuity | $25 → $34 | Maintains | Buy |
| 11/05/2019 | 64.65% | Raymond James | $20 → $30 | Maintains | Outperform |
| 11/05/2019 | 92.1% | B of A Securities | → $35 | Upgrades | Underperform → Buy |
| 11/05/2019 | 92.1% | JMP Securities | $20 → $35 | Maintains | Outperform |
| 09/17/2019 | — | B of A Securities | Downgrades | Buy → Underperform | |
| 08/20/2019 | 48.19% | Needham | $20 → $27 | Maintains | Buy |
| 08/06/2019 | 9.77% | JMP Securities | $13 → $20 | Maintains | Market Outperform |
| 08/06/2019 | 9.77% | Raymond James | → $20 | Upgrades | Market Perform → Outperform |
| 02/26/2019 | — | B of A Securities | Upgrades | Neutral → Buy | |
| 02/26/2019 | -34.14% | Canaccord Genuity | $14 → $12 | Maintains | Buy |
| 11/13/2018 | -17.67% | B of A Securities | $21 → $15 | Downgrades | Buy → Neutral |
| 11/13/2018 | -1.21% | Canaccord Genuity | $23 → $18 | Maintains | Buy |
| 11/13/2018 | -1.21% | JMP Securities | $25 → $18 | Maintains | Market Outperform |
| 07/23/2018 | 15.26% | JP Morgan | → $21 | Initiates Coverage On | → Overweight |
| 07/23/2018 | 37.21% | JMP Securities | → $25 | Initiates Coverage On | → Market Outperform |
| 07/23/2018 | 26.23% | Canaccord Genuity | → $23 | Initiates Coverage On | → Buy |
What is the target price for EverQuote (EVER)?
The latest price target for EverQuote (NASDAQ: EVER) was reported by Oppenheimer on January 19, 2023. The analyst firm set a price target for $22.00 expecting EVER to rise to within 12 months (a possible 20.75% upside). 13 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for EverQuote (EVER)?
The latest analyst rating for EverQuote (NASDAQ: EVER) was provided by Oppenheimer, and EverQuote maintained their outperform rating.
When is the next analyst rating going to be posted or updated for EverQuote (EVER)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of EverQuote, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for EverQuote was filed on January 19, 2023 so you should expect the next rating to be made available sometime around January 19, 2024.
Is the Analyst Rating EverQuote (EVER) correct?
While ratings are subjective and will change, the latest EverQuote (EVER) rating was a maintained with a price target of $8.00 to $22.00. The current price EverQuote (EVER) is trading at is $18.22, which is within the analyst's predicted range.